Previous 10 | Next 10 |
2024-03-25 02:07:51 ET Summary Sanofi has underperformed the U.S. stock market lately but now offers one of the smartest growth-at-a-reasonable-price setups in Big Pharma. Sanofi is best known for its patented drug Dupixent and numerous vaccines manufactured for global use, which ...
2024-03-24 13:38:10 ET More on the GRANOLAS Sequoia Fund - SAP SE: We See A Clear Path To Enhanced Profitability ASML: Don't Be Fooled Into Buying Its Overvalued Shares Now What AstraZeneca Is Getting Through The Acquisition Of Fusion Pharmaceuticals Mo...
2024-03-20 05:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-03-18 12:17:28 ET More on AstraZeneca 5 Reasons AstraZeneca Stock Can Rise In 2024 AstraZeneca PLC (AZN) Q4 2023 Earnings Call Transcript AstraZeneca FY23 Earnings Review: It's OK To Buy Dip On Q4 Bottom Line Miss AstraZeneca to expand rare disease pipel...
2024-03-15 13:03:38 ET More on Sanofi Sanofi (SNY) Barclays 26th Annual Global Healthcare Conference (Transcript) Sanofi (SNY) Leerink Partners Global Biopharma Conference (Transcript) Sanofi (SNY) TD Cowen 44th Annual Health Care Conference (Transcript) FDA ...
2024-03-13 10:25:19 ET Sanofi (SNY) Barclays 26th Annual Global Healthcare Conference March 13, 2024 08:00 AM ET Company Participants Naimish Patel - Global Head of Development for Immunology and Inflammation Shaju Backer - Global Head of Immunology Franchise C...
2024-03-12 14:29:05 ET Sanofi (SNY) Leerink Partners Global Biopharma Conference March 12, 2024 10:40 AM ET Company Participants Naimish Patel - Global Head of Development for Immunology and Inflammation Shaju Backer - Global Head of Immunology Franchise Confer...
2024-03-11 08:22:37 ET Summary Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investable candidates that may b...
2024-03-11 07:52:45 ET Regeneron Pharmaceuticals ( NASDAQ: REGN ) has received approval from the U.S. Food & Drug Administration (FDA) for its Praluent (alirocumab) injection to treat children with genetic form of high cholesterol.... Read the full article on Seeking A...
2024-03-08 10:21:57 ET More on Teva Pharmaceutical Teva And Alvotech: Simlandi Approval Opens New Generic Market Opportunities Teva Pharmaceutical: I Need To See Top-Line Growth Return Before Starting A Position A Review Of Teva's Prospects UroGen falls as Te...
News, Short Squeeze, Breakout and More Instantly...
Sanofi ships U.S. influenza vaccines for the 2024/25 season PR Newswire Customers will start receiving shipments from July 10 with additional shipments through October to healthcare provider offices, pharmacies and other immunizers to support fall immunization campaigns. ...
2024-07-09 06:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...